Cigna vs Regeneron (CI vs REGN)

Cigna (CI) vs Regeneron (REGN) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

Cigna (CI) and Regeneron (REGN) compete in healthcare and pharma. Here are Cigna and Regeneron side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Cigna or Regeneron.

Cigna vs Regeneron: the figures

Cigna and Regeneron figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Cigna or Regeneron figure is not available, and we never estimate it.

3 key differences between Cigna and Regeneron

1. Profitability: for every 100 of sales, Regeneron keeps 28.5 as net profit and Cigna keeps 2.3.
2. Growth: Regeneron grew sales +36.3% year on year in its latest quarter, against +6.7% for Cigna.
3. Valuation: Regeneron trades at 20.6x its annual earnings and Cigna at 12.6x; the market pays more for each dollar of Regeneron profit, usually because it expects more growth.

Cigna or Regeneron: which fits your profile

• If you want growth: Regeneron is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): Cigna pays the higher dividend relative to its price.
• If you prefer caution: Regeneron has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Cigna trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither Cigna nor Regeneron wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How Cigna and Regeneron make money

Cigna (CI)

The Cigna Group has two main platforms. Evernorth Health Services, the larger by revenue, includes pharmacy benefit manager Express Scripts and specialty pharmacy Accredo, while Cigna Healthcare sells health coverage, mainly to employers insuring their workers. The vast majority of its business is in the United States. Full Cigna analysis.

Regeneron (REGN)

Regeneron is a biotech company built on antibody drugs. It earns money from U.S. sales of Eylea for retinal eye disease and from its partnership with Sanofi on Dupixent, used for eczema and asthma, which the two companies share profits on. It also sells the cancer immunotherapy Libtayo. Full Regeneron analysis.

Frequently asked questions: Cigna vs Regeneron

Is Cigna or Regeneron the better stock?

Choosing between Cigna and Regeneron depends on what you are looking for. Regeneron is growing faster right now, and Cigna trades on the lower P/E. Fintols does not tell you whether to buy Cigna or Regeneron: it shows you the differences so you can decide.

Which pays a higher dividend, Cigna or Regeneron?

As of November 4, 2026, Cigna yields 2.11% and Regeneron yields 0.39%. Also check how much of their profit Cigna and Regeneron pay out: if it is more than they earn, it cannot last.

Which is more expensive, Cigna or Regeneron?

On P/E, Regeneron (20.6x) is more expensive than Cigna (12.6x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both Cigna and Regeneron?

Yes. Many people spread their money across several companies, such as Cigna and Regeneron, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Cigna or Regeneron.

More comparisons with Cigna or Regeneron

• Cigna vs Elevance Health
• Cigna vs Zoetis
• Elevance Health vs Regeneron
• Regeneron vs Zoetis

More companies like Cigna and Regeneron: healthcare and pharma stocks. Educational content about Cigna and Regeneron, not investment advice.